Driven by several blockbuster products, a burgeoning pipeline and the need for dedicated expertise in the myriad of technical nuances associated with biomolecules, the biopharmaceutical contract manufacturing market has a lucrative future
Roots Analysis is pleased to announce the publication of its recent study, titled, “Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030.”
The report features an extensive study on the contract service providers within the biopharmaceutical industry. The study features in-depth analyses, highlighting the capabilities of a diverse set of biopharmaceutical CMOs and contract development and manufacturing organizations (CDMOs). Amongst other elements, the report includes:
§ A detailed review of the overall landscape of companies offering biopharmaceutical contract manufacturing services.
§ A detailed landscape of the biopharmaceutical manufacturing facilities established across the key geographical regions.
§ Elaborate profiles of key players that claim to have a diverse range of capabilities related to the development, manufacturing and packaging of biologics.
§ A detailed discussion on the key enablers in this domain, including certain niche product classes, such as antibody drug conjugates (ADCs), bispecific antibodies, cell therapies, gene therapies and viral vectors.
§ A case study on the growing global biosimilars market, highlighting the associated opportunities for biopharmaceutical CMOs and CDMOs.
§ A case study comparing the key characteristics of small and large molecule drugs, along with details on the various steps involved in their respective manufacturing processes.
§ A detailed discussion on the overview, benefits and challenges associated with in-house manufacturing.
§ A qualitative analysis, highlighting the various factors that need to be taken into consideration by biopharmaceutical therapeutics / drug developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.
§ An analysis of the initiatives of big biopharma players engaged in this domain.
§ An analysis of the recent collaborations, mergers and acquisitions and expansions that have been established in this domain, in the recent past.
§ An analysis of the recent developments within the biopharmaceutical contract manufacturing industry.
§ A detailed capacity analysis, taking into consideration the individual development and manufacturing capacities of various stakeholders engaged in this domain.
§ An informed estimate of the annual demand for biologics based on several parameters.
§ A discussion on affiliated trends, key drivers and challenges, under an elaborate SWOT framework.
§ A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract manufacturing services to biopharmaceutical developers.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
§ Commonly outsourced business operations
§ API
§ FDF
To order this 780+ page report, which features 300+ figures and 270+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/biopharmaceutical-contract-manufacturing-market/250.html
§ Types of Expression Systems Used
§ Mammalian
§ Microbial
§ Others
§ Scale of Operation
§ Preclinical / Clinical
§ Commercial
§ Company Size
§ Small
§ Mid-sized
§ Large / Very Large
§ Types of Biologics Manufactured
§ Antibody Therapeutics
§ Vaccines
§ Cell Therapies
§ Other Biologics
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Latin America
§ Middle East and North Africa
To request a sample copy / brochure of this report, please visit this - https://www.rootsanalysis.com/reports/250/request-sample.html
Key companies covered in the report
§ AGC Biologics
§ Boehringer Ingelheim
§ Catalent
§ Cytiva (GE Healthcare)
§ FUJIFILM Diosynth Biotechnologies
§ KBI Biopharma
§ Kemwell Biopharma
§ Lonza
§ Luina Bio
§ Novasep
§ Olon
§ Patheon
§ Piramal Pharma Solutions
§ Takara Bio
§ WuXi AppTec (WuXi Biologics)
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/biopharmaceutical-contract-manufacturing-market/250.html or email [email protected]
You may also be interested in the following titles:
1. Vaccine Contract Manufacturing Market (3rd Edition), 2021-2030
2. ADC Contract Manufacturing Market (4th Edition), 2020-2030
3. Biopharmaceutical CMO Contract Manufacturing Biopharma Capacity Market Segment Report 58 Views
